chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first started with severe migraine and chills and then experienced difficulty breathing and shortness of breathe. Had to go to the ER because I was unable to breathe when laying down
Within 20 minutes, the pt returned to the office with facial swelling, swelling  of his throat, difficulty breathing and angioedema of the face and urticaria under his arms, neck and face. The pt was treated with Benadryl and Depromedrol.
STOMACH PAIN; BODY PAIN; CHILLS; FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced stomach pain, body pain, chills, fever, nausea, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, nausea, body pain, headache, stomach pain and chills was not reported. This report was non-serious.
In middle of September, I noticed pain in my lower back whenever I would sit for an extended time.  I had an urgency to urinate but only urinating a little bit.  I had constipation and blood in my stool.  I went to the Dr. in late December and prescribed sodium.   Experiencing kidney pain.  I was referred to a specialist.  Still waiting on test results.
TOOK ALL DOSES IN A ROW; This spontaneous case report (PVX2019-2336) was received from a consumer on 11-Sep-2019. It described a 60-year-old adult male consumer who "took all doses in a row" (PT: Inappropriate schedule of product administration), while being on oral Vivotif for typhoid prophylaxis   Case report: The consumer took all the doses of Vivotif every day from 07-Sep-2019 to 10-Sep-2019.  Action taken with Vivotif was not applicable.   The clinical outcome for the reported event was unknown.  Company's Comment: The causality of the event "took all doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took all doses in a row" was considered as not applicable.
pt waited 25 after getting vaccine in the pharmacy then went shopping in the grocery store.  30 minutes post vaccine she fell to the floor and started having seizures.  ems was called and pt was taken to the emergency room.  pt's husband was called at 3pm by pharmacy staff and she was being discharged from the hospital er.
Some of the vaccine leaked out of arm; Leaked out of arm; A spontaneous report was received from a consumer who was a female patient of unknown age, who received Moderna's covid-19 vaccine(mRNA-1273) and some of the vaccine leaked out of her arm.   The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.     On 24-Feb-2021, the patient received their second of two planned doses of mRNA-1273 (Batch number:unknown) for prophylaxis of COVID-19 infection.   During the vaccination, some of the vaccine leaked out of her arm.  The patient received both scheduled doses of mRNA-1273; therefore, action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event, vaccine leaked out, was considered recovered/resolved.; Reporter's Comments: This report refers to a case of accidental underdose and exposure via skin contact for mRNA-1273 (lot # unknown) with no associated AEs reported.
Called 3-27-09 with c/o dizziness, pain, racing heartbeat & fever.  (did not know how high).  Too dizzy to stand up.  Person suggested they go to urgent care.  They did not.  Called to check on home 3-31-09- says is fine now.
Pt had injection site reaction - according in NP she had mild redness and minor edema around injection site. She gave her 40mg IM of KENALOG to treat.
Woke on 10/30/2022 with left arm swollen from shoulder to below elbow. Inflamed. No rash. No itch. Swelling lasted until 11/05/2022. Applied ice packs several times a day.
not feeling well w/in 4hr ov vax;in 8hr had protracted nausea & vomiting & sense of impending doom;seen in ER & give antinausea med; fine by 12OCT95;
Mother states that on 10/18/00, child broke out in hives. He was taken to doctor that same day. The doctor stated the child had an allergic reaction to DTAP and doctor gave child Benadryl and another medication that mother was unable to recall the name of.
pt recv vax 22APR99 & both arms inj site w/redness approx 1in from inj site;pt seen by MD in peds clinic;
Attende reported lightheadedness immediately after vaccine administration, however opted to remain seating over the offered cot.  Frequent Vital signs taken, all within normal history of attendee (per report). Declined EMS call.  Observed for a longer span of time. Ambulated with standbyAssistx1 to bathroom, continued remainder of Observation period with improvement to point of discharge and ambulated without assistance upon departure.
Post vax, the pt was wheezy, pale and had difficulty breathing. Called the MD and he sent to ER. The pt arrived at 23:00 on 1/29/02.
Sudden onset of floaters with occasional flashes of light in right eye on Sunday, May 2 at dinner time.  Problem remained unchanged for several months, but has slowly been subsiding (but still noticeable).
I had an extremely high heart rate. BPM was 118-156 for about three hours. For three days after that, I had severe chest pain and a burning sensation in my chest.
rash on face; face heating up; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on face) and TEMPERATURE INTOLERANCE (face heating up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced RASH (rash on face) and TEMPERATURE INTOLERANCE (face heating up). At the time of the report, RASH (rash on face) and TEMPERATURE INTOLERANCE (face heating up) outcome was unknown.            No concomitant medications were provided.  No treatment details were provided.
swelling under her armpit, it is painful because it is going down the arm; swelling under her armpit, it is painful because it is going down the arm; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in left arm on 22Mar2021 around 16:00 (at the age of 42-year-old) as dose 1, single for covid-19 immunisation. Medical history included ongoing sinus issues, patient stated she started having sinus issues when she turned 40. Concomitant medication included ongoing Lisinopril taken for high blood pressure from 2019, ongoing Montelukast taken for nasal sinus issues from 2019 and ongoing Cefdinir taken for sinus issues from 15Mar2021. On 24Mar2021, the patient experienced swelling under her armpit, it was painful because it was going down the arm. She stated that it could have been last night but she knew she had to go to work and wasn't going to get out of bed.The patient was taking Pfizer COVID Vaccine for asthma, wanting to travel, want to get back to normal. No additional vaccines administered on same date of the Pfizer Suspect. Patient had no prior vaccination within four weeks. No adverse event prior vaccination. No emergency room and physician office visit. At the time of reporting,outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Pt reports "feeling yucky" 3 hours after hep A shot. Pt complained of diarrhea, nausea, mild breathing problems and fever that went from 99-102.5 that night. Fever on Wed night was higher possibly 105.3, but pt isn't sure she read thermometer right. Fever on Thurs (09/20/2001) was 99. Pt better today, just complained of "low energy".
Pt recvd 1 dose Engerix-B & exp involuntary spasm & back of arm jerked during vax; pt had tingling of that arm & fingers; then an uncomfortable feeling in chest & tingling in other fingers; BP was 140/80 -BP taken again 80/50; sore arm;
This spontaneous report as received from physician via company representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of GARDASIL (lot number, expiry date, route and dose were not reported). On an unknown date, the patient broke out in rash all over body 10 to 15 minutes after receiving a dose of GARDASIL. On an unspecified date, the event was recovered/resolved. Additional information has been requested.
Patient became sweaty dizzy and nauseous and said hand cramping related to her tourette's syndrome had started to occur about 10 minutes after the shot. Patient was made to  sit and rest close to a basin as she was anticipating vomiting and was given water to drink. No vomiting occured . After 5 to 10 more minutes patient felt better and asked to leave.
no additional adverse effects reported; a patient was administered an improperly stored dose of Rotateq; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-JUL-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) vial lot # S013890, expiration date 14-FEB-2021 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 48.7 degrees Fahrenheit for 2 hours/ 30 minutes. Data logger was involved. There were no previous excursions reported.
Body aches; Fever; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040R21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at a dose of 1 dosage form. At the time of the report, PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt developed elevated temp given APAP all night temp still 105; Also irritable; Seen by MD mom was told rxn was due to immun;
Was vaccinated with less than half of the dose; Situation with a syringe in which the patient was vaccinated with less than half of the dose; A spontaneous report was received from a health care professional concerning a patient, unknown age, who was vaccinated with less than half of the dose of Moderna's COVID-19 Vaccine (mRNA-1273).   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 03 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 028L20A) intramuscularly for prophylaxis of COVID-19 infection.   The health care professional reported there was a situation with a syringe in which the patient was vaccinated with less than half of the dose. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the events vaccinated with less than half of the dose and situation with a syringe in which the patient was vaccinated with less than half of the dose, was considered resolved on 03 Feb 2021.; Reporter's Comments: This report refers to a case of underdose and device connection issue for mRNA-1273. There were no reported AEs associated with this case.
3 vaccines given in the left lateral thigh, developing an induration that is 20 x 22 mm and fluctuant. Shots were given in an area less than 1.5 x 1.5 inches. Had similar reaction last July ending in a sterile abscess that was drained.
Patient received COVID Bivalent updated booster on 09/7/2022. At the time per EM all dose was given from syringe/needle , retracted in arm, a drop dribbled down patients arm and was cleaned appropriately. EM feels that complete dose was given and  the drop was a small amount. Patient called pharmacy 09/08/2022 in the morning and stated concern that she did not receive full dose. Patient spoke with physician and physician and physician initially believes may not have given full dose. Patient spoke with physician second time and they stated that it would be up to pharmacy to give another dose. No other additional dose was given at this time. I and EM believe full dose was given to patient.  Internal event also completed. Spoke with someone at doctor's office and noted in chart
Had a cough and took Home COVID-19 test and was positive. Contacted doctor and was prescribed Paxlovid. Took full course of prescription and tested negative 7 days later.
Pt initally had heache dizzines, n/v .  ON 5/26  admited with intracranial hemorrhage.
After receiving flu vaccine, developed raised red area at injection site (L deltoid) and warm to touch.
No additional AE reported; GARDASIL 9 was stored improperly and administered.; This spontaneous report was received from a licensed practical nurse and refers a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, medical history, concomitant medications and drug reactions or allergies   On 30-JUL-2020, the patient was vaccinated with an improperly stored dose of hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot# 1637651 and expiration date 09-JUN-2022 for prophylaxis (exact dose, route and site of administration were not reported). Administered dose of vaccine was exposed to the temperature of 50 degrees Fahrenheit (F) for 1 hour and 46 minutes. There was no previous temperature excursion. The call was because of a digital data logger. No additional adverse events were reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1637651; expirationdate: 09-JUN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2007USA012014: US-009507513-2008USA000367: US-009507513-2008USA000372: US-009507513-2008USA000266: US-009507513-2008USA000316: US-009507513-2007USA012124: US-009507513-2007USA012061: US-009507513-2007USA012060: US-009507513-2007USA012054:
Patient was given PREVNAR 13 right deltoid IM on 04-02-15, on 04-06-15 her arm developed a rash with redness, swelling and itching. She was evaluated for it on 04-09-15.
redness & bruising @ inj site;pt to use DPH & started on Keflex;
17 year old female received Moderna vaccine; A spontaneous report was received from a nurse concerning a 17-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided.  No relevant concomitant medications were reported.  On 07Jan2021, the patient received her first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  The patient was administered mRNA-1273 vaccine at age 17 on 07Jan2021 . No treatment information was provided.  Action taken with the first dose of mRNA-1273 in response to the event was not reported.    The event, a 17 year-old female patient received Moderna vaccine, was considered resolved.; Reporter's Comments: This case concerns a 17-year old female who received her first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection. There were no reported adverse events associated with this event of product administered to patient of inappropriate age.
STARTED TO FEEL CRANKY AND JUST FEELING SORE, IRRITATED.  FELT WARM AND SWEATY.  NEXT DAY STILL FEELING THE SAME.  WHEN SHE WENT TO THE DR AT 1 PM, A RED SPOT WAS NOTICED APPROX 1 1/2" AWAY FROM THE INJECTION SITE, WITH A SMALL HEAD, THE SPOT IS WARM AND RAISED.  NO LOCALIZED REDNESS OR IRRITATION NOTED AT THE INJECTION SITES.  AT THE DR OFFICE TODAY AT 1 PM, AN ANTIBIOTIC OMNICEF WAS GIVEN.  THE DR. OFFICE STATES THE RED RAISED AREAS COULD HAVE BEEN A BACTERIA IRRITATION FROM THE INJECTION OF THE VACCINE.  GRANDMA STATES THE 2 MONTH SHOTS WERE GIVEN AND PATIENT WAS ADMITTED TO HOSPITAL FOR ABX DUE TO FEVER.  BUT THEY DID NOT CONSIDER IT A VACCINE REACTION.
On 1/20/2023, patient presented to the emergency department via ambulance from the nursing home for evaluation of shortness of breath, increased need for supplemental oxygen use from 2 L to 6 L, fever, and lethargy. She had a recent hospital admission for influenza A. Patient was in respiratory distress in the ED, so she was placed on BiPAP which improved her respiratory status; She was given a COVID-19 NAA test which resulted positive; Her chest x-ray showed cardiomegaly, and atelectasis vs basilar infiltrate. Patient was treated with cefepime, azithromycin and vancomycin given the recent admission and influenza A. She was diagnosed with acute hypoxemic respiratory failure, severe sepsis secondary to possible hospital-acquired pneumonia, COVID-19 pneumonia, mild CHF exacerbation, and chronic kidney disease. Patient was admitted to the hospital for further evaluation and treatment.    Submitter does not have access to further medical information on this case including discharge date. If more information is needed, please contact the admitting hospital.
Itching all over, dizziness, tightening of throat increase heart rate, panic attacks, tendinitis, headache, shaking of right leg, and fatigue.
she had a "little bit of pain" in her arm after vaccination.; This is a spontaneous report from a Pfizer sponsored program. A contactable 83-years-old Female Consumer reported that she received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 03Feb2021 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that On an unknown date she had a "little bit of pain" in her arm after vaccination. The outcome of event was unknown.  Information on lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
experienced a ''hot, red rash with soreness and swelling" at injection site following administration of PNEUMOVAX 23; experienced a ''hot, red rash with soreness and swelling" at injection site following administration of PNEUMOVAX 23; experienced a ''hot, red rash with soreness and swelling" at injection site following administration of PNEUMOVAX 23; experienced a ''hot, red rash with soreness and swelling" at injection site following administration of PNEUMOVAX 23; This spontaneous report was received from an office manager referring to 71 year-old female patient with no known allergies. The patient's concurrent conditions included hypertension. The patient's medical history was not provided.      On 09-AUG-2019, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) per intramuscular route (unspecified dose), lot# R025296 expiration date 08-JUN-2020 for prevention of pneumococcal disease. Concomitant therapies included loratadine (CLARITIN), hydrochlorothiazide and losartan. On the same date, the patient experienced a "hot (injection site warmth), red rash (injection site rash) with soreness (injection site pain) and swelling (injection site swelling)" at injection site following administration of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). No laboratories were performed.        The outcome of injection site pain, injection site swelling, injection site rash and injection site warmth was reported as not recovered/not resolved.  The causal relationship between the events and Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was not provided.
Systemic: Chills-Severe, Systemic: Exhaustion-Severe, Systemic: Headache-Severe, Systemic: Nausea-Severe, Systemic: Other- Dizziness, Feeling Faint-Severe; symptoms lasted 1 day
vomiting and abdominal pain within 5 minutes of administration of vaccine, did not get epi pen resolved within 5 hours.
10 minutes post vaccination patient suffered a syncopal event/seizure in the observation clinic. Tonic-clonic convulsions noted by nursing staff for 30-40 seconds with loss of consciousness for aprox 1minute total. Noted cyanosis that improved with application of O2 via nasal cannula. Patient taken by hospital code team to ER. DX with dehydration, possible UTI, and syncope.
Pt cranky first day or two p/inject-APAP given that night no further problems 30May91; T103, aching all over, anorexia, swollen gland lt side throat;
Almost exactly 12 hours after I got the vaccine I started to feel really dehydrated. When I went to bed I had chills and a 100.5 fever. Throughout the night my fever had gone up to 101.3 even though I had taken ibuprofen around 10. From 1am-5am I still had my fever and was throwing up about once an hour. I fell asleep around 5:30am and woke up at 8 with a pounding headache. I was fever free the rest of the day but just fatigued with a small headache
PATIENT RECEIVED A BOOSTER OF PFIZER  WHEN SHE IS ONLY 17 YO.
No reactions occurred. Vaccine administered on 5/19/2022, however due to it being kept in the fridge, it should have expired on 4/8/22, therefore patient received expired vaccine.
Approximately 5 minutes after receiving the vaccine, the patient passed out and his eyes rolled back (possible seizure activity). This activity lasted for approximately 1 minute.  Patient also felt dizzy, sweaty,  nauseous, and became pale. Patient was given a cold ice pack to lower his body temperature. Patient was also given crackers for nausea, and a bag just incase he had to vomit. Patient's mother was also here to tend to the patient. The mother also gave him clear fluids (sprite) to help with the nausea.  After approximately 10 minutes, the patient was able to stand without feeling dizzy. He left the store with his mother to be watched closely (His mother is a nurse.) They also refused emergency medical services.